ICU MEDICAL INC/DE
Company Stats
- Market Cap
- $4.0B
- as of Sep 30, 2026
- Shares Outstanding
- 25.0M
- Free Float
- 77.9%
Income Statement
- Revenue
- $2.2B
- Operating Income
- $42.8M
- Net Income
- $732,000
- EBITDA
- $243.6M
- Revenue Growth, 3Y
- -0.7%
- FCF Margin, 3Y Avg
- 4.3%
- FCF Margin, Worst Year
- 3.6%
Cash Flow
- Free Cash Flow
- $91.8M
- FCF Yield
- 2.3%
- Owner FCF Yield
- 0.9%
Balance Sheet
- Total Debt
- $1.3B
Returns & Capital
- Share Repurchases
- $8.8M
- Buyback Yield, 3Y Avg
- 0.3%
- SBC, 3Y Avg
- $47.7M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $2.2B | $91.8M | 4.1% |
| FY2024 | $2.4B | $124.7M | 5.2% |
| FY2023 | $2.3B | $82.3M | 3.6% |
| FY2022 | $2.3B | -$152.4M | -6.7% |
| FY2021 | $1.3B | $199.0M | 15.1% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 24, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges
Healthcare Earnings: Demand Surges, Costs Bite Back